Current Issues in Quality Improvement in Cystic Fibrosis
Authors:
- 1 June 2007
- journal article
- review article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 28 (2) , 459-472
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The 100 000 Lives CampaignJAMA, 2006
- Cystic Fibrosis Adult CareChest, 2004
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional studyCommentary: Management in paediatric and adult cystic fibrosis centres improves clinical outcomeBMJ, 1998
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Cystic Fibrosis Foundation Guidelines for Patient Services, Evaluation, and Monitoring in Cystic Fibrosis CentersAmerican Journal of Diseases of Children, 1990
- Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosisThe Lancet, 1990
- Long‐term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosaPediatric Pulmonology, 1989
- Long‐term tobramycin aerosol therapy in cystic fibrosisPediatric Pulmonology, 1989
- A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and TorontoJournal of Clinical Epidemiology, 1988